SCHEMBL4161122

SCHEMBL4161122

O=C(CNC(=O)c1ccccc1)N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)NCC(O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GPR139 Q6DWJ6 7/20 0.42
MDM4 O15151 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGB1 P05556 1/20 0.40
ITGAV P06756 1/20 0.40
ITGA5 P08648 1/20 0.40
SLC6A9 P48067 7/20 0.40
SLC6A5 Q9Y345 4/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
CES1 P23141 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4158065 0.86 CES1 (0.45) HDAC1HDAC2CES1KMT2A
SCHEMBL4159834 0.83 EPHX2 (0.43) NPC1RAB9ASMN1; SMN2HDAC1HDAC2
SCHEMBL4163977 0.83 MLYCD (0.46) NPC1RAB9ASMN1; SMN2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL4158022 0.83 HDAC1 (0.38) NPC1RAB9ASMN1; SMN2HDAC1HDAC2
SCHEMBL3507605 0.81 GPR139 (0.42) GPR139SLC6A9SLC6A5HDAC1HDAC2
SCHEMBL4160412 0.81 HTT (0.46) NPC1RAB9AGPR139HDAC1HDAC2
SCHEMBL4166649 0.79 HDAC1 (0.38) NPC1RAB9ASMN1; SMN2HDAC1HDAC2
SCHEMBL4149913 0.79 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2
SCHEMBL4620748 0.78 LMNA (0.40) SMN1; SMN2MEN1KMT2A
SCHEMBL4161127 0.74 NPC1 (0.38) NPC1RAB9ASMN1; SMN2GPR139SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 NPC1 1625/4885RAB9A 1138/4885SMN1; SMN2 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.